Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoposide in Adult EBV-associated HLH
NCT03742115Phase 3Unknown
- Sponsor
- Beijing Friendship Hospital
- Start
- Dec 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etoposide in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH), sponsored by Beijing Friendship Hospital. Status: unknown.
02
Drugs
etoposide
03
Conditions
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH)
Beyond the preview
Go deeper on NCT03742115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03742115.